Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extra-fine HFA-BDP to suppress small airways inflammation in COPD
2008-005909-19Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jan 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of beclomethasone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University of Dundee. Primary endpoint: Suppression of alveolar nitric oxide (CANO). Started Jan 2009; status: completed.
02
Drugs
beclomethasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-005909-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005909-19.